These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunologic aspects of multiple sclerosis. Boppana S; Huang H; Ito K; Dhib-Jalbut S Mt Sinai J Med; 2011; 78(2):207-20. PubMed ID: 21425265 [TBL] [Abstract][Full Text] [Related]
5. [Immunological abnormalities in multiple sclerosis]. Tabira T No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805 [No Abstract] [Full Text] [Related]
6. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis. Zamvil SS; Steinman L Neuron; 2003 Jun; 38(5):685-8. PubMed ID: 12797954 [TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination. Raine CS Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521 [No Abstract] [Full Text] [Related]
8. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting. Stinissen P; Raus J Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096 [TBL] [Abstract][Full Text] [Related]
10. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets. Holmøy T Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322 [TBL] [Abstract][Full Text] [Related]
11. The good and the bad of neuroinflammation in multiple sclerosis. Naegele M; Martin R Handb Clin Neurol; 2014; 122():59-87. PubMed ID: 24507513 [TBL] [Abstract][Full Text] [Related]
12. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis. Sheremata W; Cosgrove JB; Eylar EH N Engl J Med; 1974 Jul; 291(1):14-7. PubMed ID: 4598923 [No Abstract] [Full Text] [Related]
13. [Multiple sclerosis: current immunological aspects]. Cuevas-García C Rev Alerg Mex; 2017; 64(1):76-86. PubMed ID: 28188715 [TBL] [Abstract][Full Text] [Related]
14. Multiple Sclerosis. Yamasaki R; Kira JI Adv Exp Med Biol; 2019; 1190():217-247. PubMed ID: 31760647 [TBL] [Abstract][Full Text] [Related]
16. [Immunity and neurodegeneration: new concepts in multiple sclerosis]. Lalive PH; Schluep M; Chofflon M; Du Pasquier R Rev Med Suisse; 2006 May; 2(64):1166-8, 1170. PubMed ID: 16734188 [TBL] [Abstract][Full Text] [Related]
18. The essential role of T cells in multiple sclerosis: a reappraisal. Constantinescu CS; Gran B Biomed J; 2014; 37(2):34-40. PubMed ID: 24732657 [TBL] [Abstract][Full Text] [Related]
19. Immunological aspects of axon injury in multiple sclerosis. Howe CL Curr Top Microbiol Immunol; 2008; 318():93-131. PubMed ID: 18219816 [TBL] [Abstract][Full Text] [Related]
20. Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications. Bennett JL; Stüve O Clin Neuropharmacol; 2009; 32(3):121-32. PubMed ID: 19483479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]